- Home
- MYFW vs PBYI Comparison
MYFW vs PBYI Comparison
Compare MYFW & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- PBYI
- Stock Information
- Founded
- MYFW 2002
- PBYI 2010
- Country
- MYFW United States
- PBYI United States
- Employees
- MYFW N/A
- PBYI N/A
- Industry
- MYFW Major Banks
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- PBYI Health Care
- Exchange
- MYFW Nasdaq
- PBYI Nasdaq
- Market Cap
- MYFW 172.7M
- PBYI 138.4M
- IPO Year
- MYFW 2018
- PBYI N/A
- Fundamental
- Price
- MYFW $18.75
- PBYI $2.86
- Analyst Decision
- MYFW Buy
- PBYI Strong Buy
- Analyst Count
- MYFW 2
- PBYI 1
- Target Price
- MYFW $23.25
- PBYI $7.00
- AVG Volume (30 Days)
- MYFW 27.1K
- PBYI 334.3K
- Earning Date
- MYFW 04-24-2025
- PBYI 05-01-2025
- Dividend Yield
- MYFW N/A
- PBYI N/A
- EPS Growth
- MYFW 61.11
- PBYI 37.78
- EPS
- MYFW 0.87
- PBYI 0.62
- Revenue
- MYFW $90,071,000.00
- PBYI $230,468,000.00
- Revenue This Year
- MYFW $17.74
- PBYI N/A
- Revenue Next Year
- MYFW $11.06
- PBYI N/A
- P/E Ratio
- MYFW $21.55
- PBYI $4.61
- Revenue Growth
- MYFW 8.92
- PBYI N/A
- 52 Week Low
- MYFW $13.46
- PBYI $2.23
- 52 Week High
- MYFW $22.32
- PBYI $5.34
- Technical
- Relative Strength Index (RSI)
- MYFW 49.57
- PBYI 42.27
- Support Level
- MYFW $17.52
- PBYI $2.83
- Resistance Level
- MYFW $19.00
- PBYI $2.99
- Average True Range (ATR)
- MYFW 0.91
- PBYI 0.17
- MACD
- MYFW 0.00
- PBYI -0.01
- Stochastic Oscillator
- MYFW 50.83
- PBYI 50.00
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.